Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1985 Feb 15;226(1):207–215. doi: 10.1042/bj2260207

Fibronectin binding to complement subcomponent C1q. Localization of their respective binding sites.

J Sorvillo, I Gigli, E Pearlstein
PMCID: PMC1144694  PMID: 3872121

Abstract

The interaction of purified human plasma fibronectin with the C1q subcomponent of complement was investigated by using a solid-phase radiobinding assay. 125I-fibronectin binding to native C1q, purified collagen domain (C1q-c) or globular domain (C1q-g) was compared. When the purified domains were insolubilized by binding to plastic, the C1q-c exhibited 59% of the binding demonstrated with intact C1q, whereas the C1q-g exhibited 35% of the binding. N-Terminal sequencing of the globular domain showed that a sequence of seven collagen-like amino acids was retained on each chain of the C1q-g fragment. 125I-fibronectin binding to C1q could be inhibited equally well by fluid-phase C1q and C1q-c, but not by fluid-phase C1q-g, implying that the collagen-like region retained on the C1q-g is masked in the fluid phase. In addition, studies were performed to determine which subunit(s) of C1q bind(s) fibronectin. The percentages of fibronectin bound by the A, B, and C chain of C1q were found to be 38, 21 and 41% respectively. Inhibition studies with purified 200-180 kDa, 50 kDa or 29 kDa fragments of fibronectin show that the binding site on fibronectin for C1q is the 50 kDa gelatin-binding domain.

Full text

PDF
213

Images in this article

209Fig. 1.
on p.209
211Fig. 4.
on p.211
211Fig. 5.
on p.211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betz S. J., Isliker H. Antibody-independent interactions between Escherichia coli J5 and human complement components. J Immunol. 1981 Nov;127(5):1748–1754. [PubMed] [Google Scholar]
  2. Bing D. H., Almeda S., Isliker H., Lahav J., Hynes R. O. Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4198–4201. doi: 10.1073/pnas.79.13.4198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Emmerling M. R., Johnson C. D., Mosher D. F., Lipton B. H., Lilien J. E. Cross-linking and binding of fibronectin with asymmetric acetylcholinesterase. Biochemistry. 1981 May 26;20(11):3242–3247. doi: 10.1021/bi00514a040. [DOI] [PubMed] [Google Scholar]
  4. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  5. Garcia-Pardo A., Pearlstein E., Frangione B. Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain. J Biol Chem. 1983 Oct 25;258(20):12670–12674. [PubMed] [Google Scholar]
  6. Giclas P. C., Pinckard R. N., Olson M. S. In vitro activation of complement by isolated human heart subcellular membranes. J Immunol. 1979 Jan;122(1):146–151. [PubMed] [Google Scholar]
  7. Golan M. D., Burger R., Loos M. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol. 1982 Aug;129(2):445–447. [PubMed] [Google Scholar]
  8. Gold L. I., Garcia-Pardo A., Frangione B., Franklin E. C., Pearlstein E. Subtilisin and cyanogen bromide cleavage products of fibronectin that retain gelatin-binding activity. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4803–4807. doi: 10.1073/pnas.76.10.4803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harris C., Roth S., Schmid F. R., Anderson B. Binding of fibronectin to Clq; inhibition of binding by aggregated IgG. Immunol Commun. 1981;10(7):601–609. doi: 10.3109/08820138109050713. [DOI] [PubMed] [Google Scholar]
  10. Hughes-Jones N. C., Gardner B. Reaction between the isolated globular sub-units of the complement component C1q and IgG-complexes. Mol Immunol. 1979 Sep;16(9):697–701. doi: 10.1016/0161-5890(79)90010-5. [DOI] [PubMed] [Google Scholar]
  11. Hynes R. O., Yamada K. M. Fibronectins: multifunctional modular glycoproteins. J Cell Biol. 1982 Nov;95(2 Pt 1):369–377. doi: 10.1083/jcb.95.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ingham K. C., Brew S. A., Miekka S. I. Interaction of plasma fibronectin with gelatin and complement C1q. Mol Immunol. 1983 Mar;20(3):287–295. doi: 10.1016/0161-5890(83)90068-8. [DOI] [PubMed] [Google Scholar]
  13. Isliker H., Bing D. H., Lahan J., Hynes R. O. Fibronectin interacts with Clq, a subcomponent of the first component of complement. Immunol Lett. 1982 Jan;4(1):39–43. doi: 10.1016/0165-2478(82)90075-x. [DOI] [PubMed] [Google Scholar]
  14. Kono I., Sakurai T., Kabashima T., Yamane K., Kashiwagi H. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus. Clin Exp Immunol. 1983 May;52(2):305–310. [PMC free article] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Loos M., Wellek B., Thesen R., Opferkuch W. Antibody-independent interaction of the first component of complement with Gram-negative bacteria. Infect Immun. 1978 Oct;22(1):5–9. doi: 10.1128/iai.22.1.5-9.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Menzel E. J., Smolen J. S., Liotta L., Reid K. B. Interaction of fibronectin with C1q and its collagen-like fragment (CLF). FEBS Lett. 1981 Jun 29;129(1):188–192. doi: 10.1016/0014-5793(81)80787-9. [DOI] [PubMed] [Google Scholar]
  18. Mosher D. F. Fibronectin. Prog Hemost Thromb. 1980;5:111–151. [PubMed] [Google Scholar]
  19. Nielsen H., Blom J., Larsen S. O. Human blood monocyte function in relation to age. Acta Pathol Microbiol Immunol Scand C. 1984 Feb;92(1):5–10. doi: 10.1111/j.1699-0463.1984.tb00045.x. [DOI] [PubMed] [Google Scholar]
  20. Pearlstein E., Baez L. A solid-phase radioimmunoassay for the determination of fibronectin levels in plasma. Anal Biochem. 1981 Sep 15;116(2):292–297. doi: 10.1016/0003-2697(81)90359-6. [DOI] [PubMed] [Google Scholar]
  21. Pearlstein E., Gold L. I., Garcia-Pardo A. Fibronectin: a review of its structure and biological activity. Mol Cell Biochem. 1980 Feb 8;29(2):103–128. doi: 10.1007/BF00220304. [DOI] [PubMed] [Google Scholar]
  22. Pearlstein E., Sorvillo J., Gigli I. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q. J Immunol. 1982 May;128(5):2036–2039. [PubMed] [Google Scholar]
  23. Porter R. R., Reid K. B. Activation of the complement system by antibody-antigen complexes: the classical pathway. Adv Protein Chem. 1979;33:1–71. doi: 10.1016/s0065-3233(08)60458-1. [DOI] [PubMed] [Google Scholar]
  24. Porter R. R., Reid K. B. The biochemistry of complement. Nature. 1978 Oct 26;275(5682):699–704. doi: 10.1038/275699a0. [DOI] [PubMed] [Google Scholar]
  25. Reid K. B. A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J. 1974 Jul;141(1):189–203. doi: 10.1042/bj1410189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reid K. B. Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement. Biochem J. 1976 Apr 1;155(1):5–17. doi: 10.1042/bj1550005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Saba T. M., Jaffe E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med. 1980 Apr;68(4):577–594. doi: 10.1016/0002-9343(80)90310-1. [DOI] [PubMed] [Google Scholar]
  28. Sorvillo J., Gigli I., Pearlstein E. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement. J Immunol. 1983 Sep;131(3):1400–1404. [PubMed] [Google Scholar]
  29. Tenner A. J., Lesavre P. H., Cooper N. R. Purification and radiolabeling of human C1q. J Immunol. 1981 Aug;127(2):648–653. [PubMed] [Google Scholar]
  30. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Watson J. The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J Exp Med. 1975 Jan 1;141(1):97–111. doi: 10.1084/jem.141.1.97. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES